ArticleInternational journal of molecular medicine2020

Clinically relevant GSK‑3β inhibitor 9‑ING‑41 is active as a single agent and in combination with other antitumor therapies in human renal cancer.

Tsutomu Anraku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.